205 related articles for article (PubMed ID: 36582061)
1. The Role of Flavanones as Scaffolds for the Development of New Treatments against Malaria and African and American Trypanosomiases.
Boniface PK; Ferreira EI; Fabrice FB
Mini Rev Med Chem; 2023; 23(14):1479-1498. PubMed ID: 36582061
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Flavonoid-derived Privileged Scaffolds in anti-Trypanosoma brucei Drug Discovery.
Boniface PK; Elizabeth FI
Curr Drug Targets; 2019; 20(12):1295-1314. PubMed ID: 31215385
[TBL] [Abstract][Full Text] [Related]
4. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi.
Belluti F; Uliassi E; Veronesi G; Bergamini C; Kaiser M; Brun R; Viola A; Fato R; Michels PA; Krauth-Siegel RL; Cavalli A; Bolognesi ML
ChemMedChem; 2014 Feb; 9(2):371-82. PubMed ID: 24403089
[TBL] [Abstract][Full Text] [Related]
5. Tetrasubstituted Imidazolium Salts as Potent Antiparasitic Agents against African and American Trypanosomiases.
Ghashghaei O; Kielland N; Revés M; Taylor MC; Kelly JM; Di Pietro O; Muñoz-Torrero D; Pérez B; Lavilla R
Molecules; 2018 Jan; 23(1):. PubMed ID: 29337878
[TBL] [Abstract][Full Text] [Related]
6. Triazole-containing Heterocycles: Privileged Scaffolds in Anti-
Pone KB; Dalhatou S; Paumo HK; Katata-Seru LM; Ferreira EI
Curr Drug Targets; 2022; 23(1):33-59. PubMed ID: 33845739
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
[TBL] [Abstract][Full Text] [Related]
8. Trypanocidal Essential Oils: A Review.
Morais MC; Souza JV; da Silva Maia Bezerra Filho C; Dolabella SS; Sousa DP
Molecules; 2020 Oct; 25(19):. PubMed ID: 33036315
[TBL] [Abstract][Full Text] [Related]
9. Hybrid-Compounds Against Trypanosomiases.
Nunes JA; Ferreira da Silva-Júnior E
Curr Drug Targets; 2022; 23(14):1319-1329. PubMed ID: 35579157
[TBL] [Abstract][Full Text] [Related]
10. Parasitology. Drugs to combat tropical protozoan parasites.
Gelb MH; Hol WG
Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
[No Abstract] [Full Text] [Related]
11. Structural Insight into Privileged Heterocycles as Anti-
Abbasi Shiran J; Ghanbari M; Mohammadnejadi E; Razzaghi-Asl N
Curr Top Med Chem; 2023; 23(9):736-752. PubMed ID: 36725826
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 1,3,4-Oxadiazole Derivatives as Broad-Spectrum Antiparasitic Agents.
Corfu AI; Santarem N; Luelmo S; Mazza G; Greco A; Altomare A; Ferrario G; Nasta G; Keminer O; Aldini G; Tamborini L; Basilico N; Parapini S; Gul S; Cordeiro-da-Silva A; Conti P; Borsari C
ACS Infect Dis; 2024 Jun; 10(6):2222-2238. PubMed ID: 38717116
[TBL] [Abstract][Full Text] [Related]
13. Systematic study of 1,2,3-triazolyl sterols for the development of new drugs against parasitic Neglected Tropical Diseases.
Porta EOJ; Ballari MS; Carlucci R; Wilkinson S; Ma G; Tekwani BL; Labadie GR
Eur J Med Chem; 2023 Jun; 254():115378. PubMed ID: 37084599
[TBL] [Abstract][Full Text] [Related]
14. Antiparasitic agents: new drugs on the horizon.
Mäser P; Wittlin S; Rottmann M; Wenzler T; Kaiser M; Brun R
Curr Opin Pharmacol; 2012 Oct; 12(5):562-6. PubMed ID: 22652215
[TBL] [Abstract][Full Text] [Related]
15. Current Prospects of Saponins as Promising Anti-
Kamdem BP; Boyom FF
Curr Drug Targets; 2023; 24(10):838-855. PubMed ID: 37469154
[TBL] [Abstract][Full Text] [Related]
16. Applicability of plant-based products in the treatment of Trypanosoma cruzi and Trypanosoma brucei infections: a systematic review of preclinical in vivo evidence.
Pereira RM; Greco GMZ; Moreira AM; Chagas PF; Caldas IS; Gonçalves RV; Novaes RD
Parasitology; 2017 Sep; 144(10):1275-1287. PubMed ID: 28578742
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Potential of Natural Products as Antiparasitic Agents for Neglected Tropical Diseases.
Orosco D; Mendoza AR; Meléndez CM
Curr Top Med Chem; 2024; 24(2):89-108. PubMed ID: 37842892
[TBL] [Abstract][Full Text] [Related]
18. Diamidines as antitrypanosomal, antileishmanial and antimalarial agents.
Werbovetz K
Curr Opin Investig Drugs; 2006 Feb; 7(2):147-57. PubMed ID: 16499285
[TBL] [Abstract][Full Text] [Related]
19. Bis(2-aminoimidazolines) and Bisguanidines: Synthetic Approaches, Antiparasitic Activity and DNA Binding Properties.
Dardonville C; Martínez JJN
Curr Med Chem; 2017; 24(33):3606-3632. PubMed ID: 28641558
[TBL] [Abstract][Full Text] [Related]
20. π-Delocalized Lipophilic Cations as New Candidates for Antimalarial, Antitrypanosomal and Antileishmanial Agents: Synthesis, Evaluation of Antiprotozoal Potency, and Insight into Their Action Mechanisms.
Takasu K
Chem Pharm Bull (Tokyo); 2016; 64(7):656-67. PubMed ID: 27373622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
